Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.

Below are the newest and most recently updated Shortage and Discontinuation reports.

Drug pills

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
SODIUM BICARBONATE INJECTION USP PFIZER CANADA ULC Resolved 42MG Updated Report 2021-09-25 143369
PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1% OMEGA LABORATORIES LIMITED Actual shortage 10MG Updated Report 2021-09-25 145846
PROTAMINE SULFATE INJECTION, USP FRESENIUS KABI CANADA LTD Actual shortage 10MG Updated Report 2021-09-25 145966
ROPINIROLE SANIS HEALTH INC Actual shortage 1MG Updated Report 2021-09-25 146199
ALOXI ELVIUM LIFE SCIENCES Resolved 0.5MG Updated Report 2021-09-25 145567
CEFAZOLIN FOR INJECTION, USP FRESENIUS KABI CANADA LTD Actual shortage 100G Updated Report 2021-09-25 145717
CLOPIDOGREL SANIS HEALTH INC Actual shortage 75MG Updated Report 2021-09-25 146191
MORPHINE SULFATE INJECTION, USP FRESENIUS KABI CANADA LTD Actual shortage 2MG Updated Report 2021-09-25 146195
MESNA FOR INJECTION FRESENIUS KABI CANADA LTD Actual shortage 100MG Updated Report 2021-09-24 143148
ABRAXANE FOR INJECTABLE SUSPENSION CELGENE INC Anticipated shortage 100MG Updated Report 2021-09-24 144114

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
ACT NABILONE TEVA CANADA LIMITED Discontinued 0.5MG New Report 2021-09-23 146066
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION TEVA CANADA LIMITED Discontinued 40MG New Report 2021-09-23 146061
ZOFRAN NOVARTIS PHARMACEUTICALS CANADA INC Discontinued 2MG Updated Report 2021-09-23 123900
CLINIMIX BAXTER CORPORATION To be discontinued 200MG 300MG 290MG 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG 16.6G 365MG 280MG 290MG Updated Report 2021-09-22 118612
LOZIDE SERVIER CANADA INC Discontinued 1.25MG Updated Report 2021-09-22 136084